Stockreport

TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update [Yahoo! Finance]

TuHURA Biosciences, Inc.  (HURA) 
PDF and metastatic Merkel cell carcinoma (MCC) is underway, conducted under Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) Co [Read more]